Epidemiology of hypersensitivity drug reactions
Top Cited Papers
- 1 August 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Allergy and Clinical Immunology
- Vol. 5 (4), 309-316
- https://doi.org/10.1097/01.all.0000173785.81024.33
Abstract
Hypersensitivity drug reactions are but one of the many different types of adverse drug reactions. They may be potentially life-threatening, prolong hospitalization, affect drug prescribing patterns of physicians and result in socioeconomic costs. This review summarizes current knowledge on the incidence, prevalence, mortality and risk factors for these reactions in different populations. Hypersensitivity reactions represent about one third of all adverse drug reactions. Adverse drug reactions affect 10–20% of hospitalized patients and more than 7% of the general population. Severe reactions including anaphylaxis, drug hypersensitivity syndromes, Stevens Johnson syndrome and toxic epidermal necrolysis are also associated with significant morbidity and mortality. Although several risk factors have been identified, their clinical importance has not been fully understood. Future progress in immunogenetics and pharmacogenetics may help identify populations at risk for specific types of reactions. Well designed epidemiological studies on hypersensitivity drug reactions are lacking as most studies have been on adverse drug reactions. Such studies will be helpful in identifying patients at risk of developing such reactions, in particular severe reactions, and implementing early preventive measures.Keywords
This publication has 76 references indexed in Scilit:
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Evaluation of the Extent of Under-Reporting of Serious Adverse Drug ReactionsDrug Safety, 2004
- Drug allergy in a general hospital: results of a novel prospective inpatient reporting systemAnnals of Allergy, Asthma & Immunology, 2003
- Lack of Awareness of Community-Acquired Adverse Drug Reactions Upon Hospital AdmissionDrug Safety, 2003
- Assessing the Feasibility of Using an Adverse Drug Reaction Preventability Scale in Clinical PracticeDrug Safety, 2002
- Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985–1996)Annals of Allergy, Asthma & Immunology, 2001
- Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivityAnnals of Allergy, Asthma & Immunology, 2000
- The Value of Reporting Therapeutic Ineffectiveness as an Adverse Drug ReactionDrug Safety, 2000
- Detection of Patients with Multiple Drug Allergy Syndrome by Elective Tolerance TestsAnnals of Allergy, Asthma & Immunology, 1998
- Atopy and systemic reactions to drugsAllergy, 1990